Heather Renee Williams, MD

Full Member

Research Program:

Cancer Therapeutics

Faculty Rank:

Assistant Professor

Campus:

University of Arkansas for Medical Sciences

College:

College of Medicine

Department:

OB & GYN Gynecologic Oncology

Cancer Research Interest

Disease Site Focus: Gynecology
Research Focus Area: Prevention, Health Disparities, Treatment, Diagnosis/ Prognosis
Type of Research: Clinical
Research Keywords: I direct the clinical trial portfolio for gyn onc
Research Interest Statement: I am currently the Clinical Trial Director for the Gyn Onc Division and serve as the PI for several trials sponsored by NRG and GOG partners. I am the site PI for GOG Partners. Since coming to this role in 2022, I have been focused on expanding our portfolio and increasing our trial enrollment. I have an interest in health disparities and their impact on cancer development and prognosis. I am also interested in support services for patients undergoing treatments and issues related to survivorship. Our site is participating in a national trial evaluating support for black women receiving treatment for endometrial cancer and we have exceeded our original enrollment goal.

“NRG CC008, A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer AmongBRCA1 Carriers [SOROCk]” (NCT04251052)
“A Phase 3, Randomized, Open-Label Study of Combination Therapy with Avutometinib plus Defactinib Versus Investigator’s Choice of Treatment in Patients with Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)” (NCT06072781)
“A Phase 2 Study of ACR-368 Therapy in Subjects with Endometrial Cancer” (NCT05548296)
“NRG-GY026: A Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) or pertuzumab trastuzumab and hyaluronidase-zzfx (PHESGO) in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma” (NCT05256225)

Nichols M, Kesaria A, Spencer HJ, [et al., including Williams HR]. Opioid Use in Patients With Cervical Cancer at a Tertiary Academic Medical Center. Anticancer research. 2024 44(1):151-155. PMID: 38160002.
Hamza MA, Quick CM, Williams HR, [et al.]. HPV-associated Vulvar Intraepithelial Carcinoma With Sebaceous Differentiation: Report of 2 Cases. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2023 42(4):338-346. PMID: 36383010.